Nursing Commission News
The U.S. Supreme Court is expected to release an opinion in June 2022 that could impact the current Roe v. Wade ruling. The professional health care regulators of the State of Washington recognize that if Roe v. Wade is impacted it could raise practice concerns for our licensees.
The Washington State Board of Health (Board) has adopted a seventh emergency rulemaking order to continue the requirements established in WAC 246-101-017 – Novel Coronavirus (SARS-CoV-2), Coronavirus Disease 2019 (COVID-19) Reporting. The emergency rule is effective April 20, 2022 and will be in effect for 120 days. The CR-103E announces the emergency rulemaking order, filed as WSR 22-09-082 (attached).
As trusted sources of medical information, you play a critical role in increasing COVID-19 vaccinations.
Join the more than 65,000 WA health care providers who have already committed to educating and empowering their patients to vaccinate, helping protect the health and wellbeing of all our communities.
SEEK: Seek your patients' COVID-19 vaccination status.
Does the Nursing Commission have a copy of your advanced registered nurse practitioner (ARNP) national certification? All active ARNP licenses in Washington State require proof of a current National Certification.
We’re redesigning the Nursing Commission’s website to better meet your needs, and we need your help. Please take our short online survey by Wednesday, April 6th, to give us feedback on the website.
Apply through May 5, 2022 at 7:30 PM ET The NHSC Scholarship Program participants agree to provide a one year service commitment in an underserved community for each year of scholarship support received. There is a two year minimum service commitment and participants can receive a maximum of four years of support. The 2022 National Health Service Corps Scholarship Program (NHSC SP) is now accepting applications from health professional students studying to become physicians, dentists, nurse practitioners, nurse midwives or physician assistants.
On April 4, 2022 NCQAC is reinstating late fees for all late license renewals and reactivations.
Recently, the U.S. Food and Drug Administration (FDA) alerted healthcare professionals to the potential risks of compounded ketamine nasal spray.
The compounded ketamine is being used to treat psychiatric disorders. Unlike the Schedule III nasal spray treatment, Spravato (esketamine), compounded ketamine nasal spray is not FDA-approved and has no FDA-approved dosing regimen.
The new Certificate in Population Health Equity is now offered through the School of Nursing at the University of Washington.
During a recent update to the Washington State Department of Health website, including our Nursing Commission site, some links were changed or broken.